3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Carcinoma
5
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Mouth Neoplasms
3
Colorectal Neoplasms
3
Adenocarcinoma
3
Skin Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Mycosis Fungoides
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell
2
Laryngeal Neoplasms
2
Glioblastoma
2
Fallopian Tube Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Breast Neoplasms
2
Vaccinia
1
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Resectable Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Interventions
fludarabine
3
aldesleukin
3
Specimen Handling
3
Fluorouracil
3
Cyclophosphamide
3
Bevacizumab
3
Sunitinib
2
Leucovorin
2
trastuzumab deruxtecan
1
sodium propionate
1
semaglutide
1
repotrectinib
1
patritumab deruxtecan
1
isosorbide-5-mononitrate
1
fludarabine phosphate
1
dehydroftorafur
1
Ultrasonography
1
Tretinoin
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Radiosurgery
1
Psilocybin
1
Positron-Emission Tomography
1
Photography
1
Pemetrexed
1
Pafolacianine
1
Oxaliplatin
1
Oviposition
1
Memantine
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
cemiplimab
×
30 days
×
Clear all
No trials found.